Ferrando RFJ

Language: Spanish
References: 9
Page: 120-122
PDF size: 675.58 Kb.

ABSTRACT

Keratoacanthoma is a rapidly growing tumour that histologically resembles squamous cell carcinoma. Most common treatment of keratoacanthoma is excision that allows histological classification, but sometimes due to its size or localization, this treatment is extremely complicated. Recently. several cases of keratoacanthoma treated with imiquimod 5% cream has been described. We present a 55-years-old woman with a keratoacanthoma on the right side of the upper and lower eyelid of the left eye treated with success with imiquimod 5% cream.

REFERENCES

1. Ramselaar CG, Van der Meer JB. The spontaneous regression of keratoacanthoma in man. Acta Dermatovnereol 1976; 56: 245-51.

2. Patel A, Haliday GM, Cooke BE, Barnetson MS. Evidence that regression in keratoacanthoma is inmunologically mediated: a comparison with squamous cell carcinoma. Br J Dermatol 1994; 131: 789-98.

3. Dendorfer M, Oppel T.,Wollenberg A. Topical treatment with imiquimod may induce regression of facial keratoacanthoma. Eur J Dermatol 2003; 13: 80-2.

4. Navi D, Huntley A. Imiquimod 5 percent cream and the treatment of cutaneous malignancy. Dermatol Online J 2004; 10:4.

5. Di Lernia V, Ricci C, Albertini G. Spontaneous regression of keratoacanthoma can be promoted by topical treatment with imiquimod cream. J Eur Acad Dermatol Venereol 2004; 18: 626-9.

6. Denkler K, Kivett WF. Topical treatment of nasal keratoacanthoma. Plast Reconstr Surg 2006; 117: 2516-7.

7. Divers AK, Correale D, Lee JB. Keratoacanthoma centrifugum marginatum: a diagnostic and therapeutic challenge. Cutis 2004; 73: 257-62.

8. Bhatia N. Imiquimod as a possible treatment for keratoacanthoma. J Drugs Dermatol 2004; 3: 71-4.

9. D’Addario S, Carrington PR. Multiple keratoacanthomas as an untoward response to imiquimod therapy for actinic keratoses. Acta Derm Venereol 2006; 86: 366-7.